Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-16-005597
Filing Date
2016-02-12
Accepted
2016-02-12 11:11:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 VENBIO SELECT ADVISOR LLC p16-0425sc13g.htm SC 13G 47131
  Complete submission text file 0000902664-16-005597.txt   48640
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87670 | Film No.: 161416144
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 415-800-0800
venBio Select Advisor LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G